Almost all participants in the SPRINT trial with hypertension and nondiabetic chronic kidney disease (CKD) stages 3–4 benefitted from a systolic blood pressure target of <120 mm Hg compared with a target of <140 mm Hg.1
These findings…

Almost all participants in the SPRINT trial with hypertension and nondiabetic chronic kidney disease (CKD) stages 3–4 benefitted from a systolic blood pressure target of <120 mm Hg compared with a target of <140 mm Hg.1
These findings…